Holen Sie sich die Stockscreener-App
18.33
0.63%
0.158
Amphastar Pharmaceuticals Inc Aktie (AMPH) Neueste Nachrichten
Amphastar Pharmaceuticals (NASDAQ:AMPH) Reaches New 12-Month LowShould You Sell? - MarketBeat
Risk Report: Can Amphastar Pharmaceuticals Inc maintain its current growth rateRate Hike & Daily Profit Maximizing Trade Tips - baoquankhu1.vn
Amphastar reports FDA approval for teriparatide injection - MSN
AMPH SEC FilingsAmphastar Pharma 10-K, 10-Q, 8-K Forms - Stock Titan
Aug Shorts: Can Amphastar Pharmaceuticals Inc maintain its current growth rateJuly 2025 Price Swings & Real-Time Market Sentiment Alerts - baoquankhu1.vn
Can Amphastar Pharmaceuticals Inc. stock reach $100 price targetIPO Watch & Daily Profit Maximizing Trade Tips - Naître et grandir
Risk Check: Is Amphastar Pharmaceuticals Inc a potential multi baggerGold Moves & High Accuracy Swing Trade Signals - baoquankhu1.vn
Vanguard Group Inc. Has $70.12 Million Stock Position in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Generic Pharmaceuticals Q4 2025 Review: Revenue Beat, Stock DeclineNews and StatisticsIndexBox - IndexBox - Market Intelligence Platform
Amphastar Pharmaceuticals signs new executive employment agreements - Investing.com UK
Amphastar Pharmaceuticals signs new executive employment agreements By Investing.com - Investing.com UK
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know - Yahoo Finance
Amphastar Updates Executive Employment Agreements to Strengthen Leadership - TipRanks
Amphastar Pharmaceuticals- Nanjing Pharmaceuticals Enters Supply Agreement With Nanjing Letop Biotechnology On March 3SEC Filing - TradingView
Amphastar Pharmaceuticals (NASDAQ:AMPH) Sets New 1-Year LowShould You Sell? - MarketBeat
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), Amphastar Pharmaceuticals Inc has signed a five-year supply agreement, under which all payments will be settled in RMB. - Bitget
Amphastar Pharmaceuticals Balances Growth Plans With Margin Risks - TipRanks
Generic Pharmaceuticals Stocks Q4 Highlights: Amphastar Pharmaceuticals (NASDAQ:AMPH) - Finviz
Amphastar Pharmaceuticals Hits Day Low of $19.83 Amid Price Pressure - Markets Mojo
Amphastar Pharmaceuticals Stock Plummets to New 52-Week Low of $19.83 - Markets Mojo
Royce & Associates LP Raises Stock Holdings in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
Amphastar Pharmaceuticals to Present at the Barclays 28th Annual Global Healthcare Conference - ACCESS Newswire
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Potential Upside of 38% Attracts Investor Attention - DirectorsTalk Interviews
Wells Fargo Sees Amphastar Pharmaceuticals, Inc.'s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth - Finviz
Wells Fargo Sees Amphastar Pharmaceuticals, Inc.’s (AMPH) AMP-007 as Key to Mid- to High-Single-Digit Growth - Yahoo Finance
Cash per share of Amphastar Pharmaceuticals, Inc. – DUS:29A - TradingView
Amphastar FDA Wins And Pipeline Expansion Contrast With Weak Earnings And Valuation - Yahoo Finance
Amphastar: Higher Costs, Lower Growth, And A 'Value Trap' Label (NASDAQ:AMPH) - Seeking Alpha
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Q4 2025 Earnings Call Transcript - Insider Monkey
Amphastar Pharmaceuticals Stock Hits New 12-Month Low After Analyst Downgrade - National Today
AMPH Stock (-24%): Q4 Earnings Miss Sparks Aggressive Liquidation - Trefis
Amphastar Pharmaceuticals Q4 2025 Report: Revenue Miss, Stock DeclineNews and Statistics - IndexBox
Amphastar Pharmaceuticals (NASDAQ:AMPH) Hits New 12-Month Low After Analyst Downgrade - MarketBeat
Amphastar stock hits 52-week low at $20.38 By Investing.com - Investing.com Australia
Amphastar Pharmaceuticals (NASDAQ:AMPH) Issues Quarterly Earnings Results - MarketBeat
Amphastar Pharmaceuticals Inc (29A.BE) Stock Price, News, Quote & History - Yahoo Finance
Amphastar stock hits 52-week low at $20.38 - Investing.com
TD Asset Management Reduces Stake in Amphastar Pharmaceuticals - National Today
Why Amphastar Pharmaceuticals (AMPH) Shares Are Plunging Today - Finviz
Wells Fargo & Company Has Lowered Expectations for Amphastar Pharmaceuticals (NASDAQ:AMPH) Stock Price - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shares Gap Down Following Analyst Downgrade - MarketBeat
Amphastar Pharmaceuticals (NASDAQ:AMPH) Price Target Lowered to $30.00 at Needham & Company LLC - MarketBeat
Amphastar Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Needham cuts Amphastar stock price target on Q4 miss, weak sales - Investing.com
TD Asset Management Inc Sells 103,038 Shares of Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Amphastar Stock Pre-Market (-15%): Q4 Earnings and Revenue Miss - Trefis
Amphastar Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
Compared to Estimates, Amphastar (AMPH) Q4 Earnings: A Look at Key Metrics - Yahoo Finance
Amphastar Pharmaceuticals Inc reports results for the quarter ended September 30Earnings Summary - TradingView
Earnings call transcript: Amphastar’s Q4 2025 Misses Estimates, Stock Dips By Investing.com - Investing.com Canada
Amphastar (AMPH) Q4 2025 Earnings Call Transcript - AOL.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Misses Q4 CY2025 Revenue Estimates, Stock Drops 11.7% - Finviz
Amphastar Pharmaceuticals (AMPH) Q4 Earnings and Revenues Lag Estimates - Yahoo Finance
Amphastar Pharmaceuticals Inc. (AMPH) Stock Falls on Q4 2025 Earnings - Quiver Quantitative
Amphastar Pharmaceuticals Inc. (AMPH) stock falls on Q4 2025 Earnings - Quiver Quantitative
Amphastar Pharmaceuticals Reports Financial Results for Q4 and Full Year 2025 - TradingView
Earnings Flash (AMPH) Amphastar Pharmaceuticals, Inc. Reports Q4 Revenue $183.1M, vs. FactSet Est of $190.1M - marketscreener.com
Earnings Flash (AMPH) Amphastar Pharmaceuticals, Inc. Posts Q4 Adjusted EPS $0.73 per Share, vs. FactSet Est of $0.92 - marketscreener.com
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2025 - ACCESS Newswire
Earnings Summary: Amphastar Pharma Q4 - Benzinga
Amphastar Pharmaceuticals Q4 2025 Earnings: Release Date & Analyst OutlookNews and Statistics - IndexBox
Amphastar earnings on deck: Can pipeline offset flat growth? By Investing.com - Investing.com UK
0.00%
1.29%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):